EpicentRx
EpicentRx is a United States-based biotechnology company running 3 late-stage cancer trials in sarcomas, head and neck squamous cell carcinoma and small-cell lung cancer.
Overview
EpicentRx, based in La Jolla, the United States, is a biotechnology company. EpicentRx is a clinical-stage company developing therapies for inflammatory diseases and supportive care conditions, including an oncolytic virus immunotherapy and a small molecule for treatment-related toxicities. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3) in sarcomas, head and neck squamous cell carcinoma, small-cell lung cancer and non-small-cell lung cancer. The largest, NCT05566041 (A Phase 3, Controlled, Open-label, Global Randomised Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer), plans to enrol 292 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyQBiotics
Shares Sarcomas (soft tissue, bone, GIST), Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyGenprex
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyAP Biosciences
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyVyriad
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyHaihe Biopharma
Shares Sarcomas (soft tissue, bone, GIST), Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyRanok Therapeutics (Hangzhou)
Shares Sarcomas (soft tissue, bone, GIST) and the tag ctgov-sponsor.
- CompanyAvistone Biotechnology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMaia Biotechnology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.